GENTIBIO
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complementary technologies needed to... successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system. GentiBio is a Seattle, Washington-headquartered company launched in 2020 by Adel Nada, Chandra Patel, and Andy Walker.
GENTIBIO
Social Links:
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.gentibio.com
Total Employee:
1+
Status:
Active
Total Funding:
177 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
AavantiBio
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
JDRF T1D Fund
JDRF T1D Fund investment in Series A - GentiBio
Novartis Venture Fund
Novartis Venture Fund investment in Series A - GentiBio
RA Capital Management
RA Capital Management investment in Series A - GentiBio
Avidity Partners
Avidity Partners investment in Series A - GentiBio
Seattle Children's Hospital and Research Institute
Seattle Children's Hospital and Research Institute investment in Series A - GentiBio
Matrix Capital Management
Matrix Capital Management investment in Series A - GentiBio
OrbiMed
OrbiMed investment in Series A - GentiBio
RA Capital Management
RA Capital Management investment in Seed Round - GentiBio
OrbiMed
OrbiMed investment in Seed Round - GentiBio
Novartis Venture Fund
Novartis Venture Fund investment in Seed Round - GentiBio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-01 | GentiBio Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer |
| 2022-02-10 | GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer |
Official Site Inspections
http://www.gentibio.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
